Future Tools for Early Diagnosis and Monitoring of Musculoskeletal Injury: Biomarkers and CT

Veterinary Clinics of North America - Equine Practice

Volumn 24, Issue 1, 2008, Pages 153-175

  van Weeren, P René ^a   Firth, Elwyn C ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b MASSEY UNIVERSITY   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ANIMAL; ANIMAL DISEASE; ARTHROPATHY; BONE; COMPUTER ASSISTED TOMOGRAPHY; HORSE; HORSE DISEASE; INJURY; METABOLISM; METHODOLOGY; MUSCULOSKELETAL SYSTEM; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; BONE AND BONES; HORSE DISEASES; HORSES; JOINT DISEASES; MUSCULOSKELETAL SYSTEM; TOMOGRAPHY, X-RAY COMPUTED;

EID: 39749110132     PISSN: 07490739     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cveq.2007.11.008     Document Type: Review

References (117)

1. Rossdale P.D., Hopes R., Wingfield Digby N., et al. Epidemiological study of wastage among racehorses 1982 and 1983. Vet Rec 116 (1985) 66-69
2. Olivier A., Nurton J.P., and Guthrie A.J. An epizoological study of wastage in Thoroughbred racehorses in Gauteng, South Africa. J S Afr Vet Assoc 68 (1997) 125-129
3. Williams R.B., Harkins L.S., Hammond C.J., et al. Racehorse injuries, clinical problems and fatalities recorded on British racecourses from flat racing and National Hunt racing during 1996, 1997 and 1998. Equine vet J 33 (2001) 478-486
4. Todhunter R.J., and Lust G. Synovial joint anatomy, biology, and pathobiology. In: Auer J.A. (Ed). Equine surgery. 1st edition (1992), WB Saunders, Philadelphia 844-866
5. Bertone A.L. The metacarpus and metatarsus. In: Stashak T.S. (Ed). Adams' lameness in horses. 5th edition (2002), Lippincott Williams & Wilkins, Philadelphia 800-816
6. Ruggles A.J. Carpus. In: Auer J.A., and Stick J.A. (Eds). Equine surgery. 3rd edition (2006), Saunders, St. Louis 1253-1266
7. Lavagnino M., Arnoczky S.P., Egerbacher M., et al. Isolated fibrillar damage in tendons stimulates local collagenase mRNA expression and protein synthesis. J Biomech 39 (2006) 2355-2362
8. Rousseau J.C., and Delmas P.D. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol 3 (2007) 346-356
9. Frisbie D.D. Synovial joint biology and pathobiology. In: Auer J.A., and Stick J.A. (Eds). Equine surgery. 3rd edition (2006), Saunders, St. Louis 1036-1055
10. Abramson S., and Krasnokutsky S. Biomarkers in osteoarthritis. Bull NYU Hosp Jt Dis 64 (2006) 77-81
11. Kiviranta P., Toyras J., Nieminen M.T., et al. Comparison of novel clinically applicable methodology for sensitive diagnostics of cartilage degeneration. Eur Cell Mater 13 (2007) 46-55
12. Benninghoff A. Form und Bau der Gelenkknorpel in ihren Beziehungen zur Function. II. Der Aufbau des Gelenkknorpels in seinen Beziehungen zur Function. Z Zellforsch Mikrosk Anat 2 (1925) 783-862
13. Attur M.G., Dave M., Akamatsu M., et al. Osteoarthritis or osteoarthrosis: the definition of inflammation becomes a semantic issue in the genomic era of molecular medicine. Osteoarthritis Cartilage 10 (2002) 1-4
14. Maroudas A. Metabolism of cartilaginous tissues. A quantitative approach. In: Maroudas A., and Holborrow J. (Eds). Studies in joint disease vol. 1 (1980), Pitman Medical, Tunbridge Wells (UK) 59-86
15. Maroudas A., Palla G., and Gilav E. Racemization of aspartic acid in human articular cartilage. Connect Tissue Res 28 (1992) 161-169
16. Hunter W. On the structure and diseases of articulating cartilage. Philosophical Transactions of the Royal Society of London 42 (1743) 514-521
17. Nelson F., Dahlberg L., Laverty S., et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 102 (1998) 2115-2125
18. Frisbie D.D., Ray C.S., Ionescu M., et al. Measurement of synovial fluid and serum concentrations of the 846 epitope of chondroitin sulfate and of carboxy propeptides of type II procollagen for diagnosis of osteochondral fragmentation in horses. Am J Vet Res 60 (1999) 306-309
19. Robion F.C., Doizé B., Bouré L., et al. Use of synovial fluid markers of cartilage synthesis and turnover to study effects of repeated intraarticular administration of methylprednisolone acetate on articular cartilage in vivo. J Orthop Res 19 (2001) 250-258
20. Billinghurst R.C., Brama P.A.J., van Weeren P.R., et al. Evaluation of serum concentrations of biomarkers of skeletal metabolism and results of radiography as indicators of severity of osteochondrosis in foals. Am J Vet Res 65 (2004) 143-150
21. Van Weeren P.R. Osteochondrosis. In: Auer J.A., and Stick J.A. (Eds). Equine surgery. 3rd edition (2006), Saunders, St. Louis 1166-1178
22. De Grauw J.C., Brama P.A.J., Wiemer P., et al. Cartilage-derived biomarkers and lipid mediators of inflammation in horses with osteochondritis dissecans of the distal intermediate ridge of the tibia. Am J Vet Res 67 (2006) 1156-1162
23. Laverty S., O'Kouneff S., Ionescu M., et al. Excessive degradation of type II collagen in articular cartilage in equine osteochondrosis. J Orthop Res 20 (2002) 1282-1289
24. Laverty S., Ionescu M., Marcoux M., et al. Alterations in cartilage type-II procollagen and aggrecan contents in synovial fluid in equine osteochondrosis. J Orthop Res 18 (2000) 399-405
25. Billinghurst R.C., Brama P.A.J., van Weeren P.R., et al. Significant exercise-related changes in the serum levels of two biomarkers of collagen metabolism in young horses. Osteoarthritis Cartilage 11 (2003) 760-769
26. De Grauw J.C., van de Lest C.H., Van Weeren P.R., et al. Arthrogenic lameness of the fetlock: synovial fluid markers of inflammation and cartilage turnover in relation to clinical joint pain. Equine Vet J 38 (2006) 305-311
27. Sugiyama S., Itokazu M., Suzuki Y., et al. Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 62 (2003) 27-32
28. Cahue S., Sharma L., Dunlop D., et al. The ratio of type II collagen breakdown to synthesis and its relationship with the progression of knee osteoarthritis. Osteoarthritis Cartilage 15 (2007) 819-823
29. Bramono D.S., Richmond J.C., Weitzel P.P., et al. Matrix metalloproteinases and their clinical applications in orthopaedics. Clin Orthop Relat Res 428 (2004) 272-285
30. Chu Q., Lopez M., Hayashi K., et al. Elevation of a collagenase generated type II collagen neoepitope and proteoglycan epitopes in synovial fluid following induction of joint instability in the dog. Osteoarthr Cartilage 10 (2002) 662-669
31. Fraser A., Fearon U., Billighurst R.C., et al. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation. Arthritis Rheum 48 (2003) 3085-3095
32. Céleste C., Ionescu M., Poole R.A., et al. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid. J Orthop Res 23 (2005) 602-610
33. Van den Boom R., Brama P.A.J., Kiers G., et al. Assessment of the effects of age and joint disease on hydroxyproline and glycosaminoglycan concentrations in synovial fluid from the metacarpophalangeal joint of horses. Am J Vet Res 65 (2004) 296-302
34. Maldonado R., Garces H., Auba J., et al. Synovial aldehyde groups in equine joint disease. Equine Vet J 15 (1983) 168-169
35. Van den Boom R., van der Harst M.R., Brommer H., et al. Relationship between synovial fluid levels of glycosaminoglycans, hydroxyproline and general MMP activity and the presence and severity of articular cartilage change on the proximal articular surface of PI. Equine Vet J 37 (2005) 19-25
36. Gangl M., Serteyn D., Lejeune J.P., et al. A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Res Vet Sci 82 (2007) 68-75
37. 2) for studying oxidative-related type III collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis Cartilage 13 (2005) 258-265
38. Farndale R.W., Buttle D.J., and Barrett A.J. Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue. Biochim Biophys Acta 883 (1986) 173-177
39. Alwan W.H., Carter S.D., Bennett D., et al. Cartilage breakdown in equine osteoarthritis: measurement of keratan sulphate by an ELISA system. Res Vet Sci 49 (1990) 56-60
40. Alwan W.H., Carter S.D., Bennett D., et al. Glycosaminoglycans in horses with osteoarthritis. Equine Vet J 23 (1991) 44-47
41. Palmer J.L., Bertone A.L., and McClain H. Assessment of glycosaminoglycan concentration in equine synovial fluid as a marker of joint diseases. Can J Vet Res 59 (1995) 205-212
42. Saxne T, Heinegård D, Wollheim FA, et al. Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis. Lancet 326:127-8.
43. Fuller C.J., Barr A.R., Sharif M., et al. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 9 (2001) 49-55
44. Little C.B., Hilbert B.J., Wickstrom S., et al. Quantitative microanalysis of equine synovial fluid glycosaminoglycan concentration. Am J Vet Res 51 (1990) 1534-1539
45. Belcher C., Yaqub R., Fawthrop F., et al. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56 (1997) 299-307
46. McIlwraith C.W. Use of synovial fluid and serum biomarkers in equine bone and joint disease: a review. Equine Vet J 37 (2005) 473-482
47. Van den Boom R., van de Lest C.H.A., Bull S., et al. Influence of repeated arthrocentesis and exercise on synovial fluid concentrations of nitric oxide, prostaglandin E2 and glycosaminoglycans in healthy equine joints. Equine Vet J 37 (2005) 250-256
48. Fradette M.E., Céleste C., Richard H., et al. Effects of continuous oral administration of phenylbutazone on biomarkers of cartilage and bone metabolism in horses. Am J Vet Res 68 (2007) 128-333
49. Bello A.E., Garrett Jr. W.E., Wang H., et al. Comparison of synovial fluid cartilage marker concentrations and chondral damage assessed arthroscopically in acute knee injury. Osteoarthritis Cartilage 5 (1997) 419-426
50. Hazell P.K., Dent C., Fairclough J.A., et al. Changes in glycosaminoglycan epitope levels in knee joint fluid following injury. Arthritis Rheum 38 (1995) 953-959
51. Dart A.J., Little C.B., Hughes C.E., et al. Recombinant equine growth hormone administration: effects on synovial fluid biomarkers and cartilage metabolism in horses. Equine Vet J 35 (2003) 302-307
52. Todhunter R.J., Yeager A.E., Freeman K.P., et al. Keratan sulfate as a marker of articular cartilage catabolism and joint treatment in ponies. Am J Vet Res 54 (1993) 1007-1016
53. Okumura M., Fujinaga T., Urakawa E., et al. Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulfate concentration in foals. Am J Vet Res 58 (1997) 925-929
54. Okumura M., Tagami M., and Fujinaga T. Consideration of the role of antigenic keratan sulphate reacting to a 1/14/16Hp antibody as a molecular marker to monitor cartilage metabolism in horses. J Vet Med Sci 62 (2000) 281-285
55. Okumura M., Kim G.H., Tagami M., et al. Serum keratan sulphate as a cartilage metabolic marker in horses: the effect of exercise. J Vet Med A Physiol Pathol Clin Med 49 (2002) 195-197
56. Heinegård D., Lorenzo P., and Saxne T. Matrix glycoproteins and proteoglycans in cartilage. In: Harris E.D., Budd R.C., Firestein G.S., et al. (Eds). Kelley's textbook of rheumatology (2005), Elsevier Saunders, Philadelphia 48-62
57. Cherdchutham W., Becker C., Smith R.K.W., et al. Age-related changes and the effect of exercise on the molecular composition of immature equine superficial digital flexor tendons. Equine Vet J Suppl 31 (1999) 86-94
58. Helal I.E., Misumi K., Tateno O., et al. Effect of exercise on serum concentration of cartilage oligomeric matrix protein in Thoroughbreds. Am J Vet Res 68 (2007) 134-140
59. Andersson M.L., Thorstensson C.A., Roos E.M., et al. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskelet Disord 7 (2006) 98
60. Misumi K., Vilim V., Clegg P., et al. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids. Osteoarthritis Cartilage 9 (2001) 119-127
61. Arai K., Misumi K., Carter S.D., et al. Analysis of cartilage oligomeric matrix protein (COMP) degradation and synthesis in equine joint disease. Equine Vet J 37 (2005) 31-36
62. Skiöldebrand E., Lorenzo T., Zunino L., et al. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints. Equine Vet J 33 (2001) 394-402
63. Skiöldebrand E., Heinegård D., Eloranta M.L., et al. Enhanced concentration of COMP (cartilage oligomeric matrix protein) in osteochondral fractures from racing Thoroughbreds. J Orthop Res 23 (2005) 156-163
64. Taylor S.E., Weaver M.P., Pitsillides A.A., et al. Cartilage oligomeric matrix protein and hyaluronan levels in synovial fluid from horses with osteoarthritis of the tarsometatarsal joint compared to a control population. Equine Vet J 38 (2006) 502-507
65. Misumi K., Vilim V., Hatazoe T., et al. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis. Equine Vet J 34 (2002) 602-608
66. Misumi K., Tagami M., Kamimura T., et al. Urine cartilage oligomeric matrix protein (COMP) measurement is useful in discriminating the osteoarthritic Thoroughbreds. Osteoarthritis Cartilage 14 (2006) 1174-1180
67. Clegg P.D., Coughlan A.R., Riggs C.M., et al. Matrix metalloproteinases 2 and 9 in equine synovial fluids. Equine Vet J 29 (1997) 343-348
68. Brama P.A.J., TeKoppele J.M., Beekman, et al. Matrix metalloproteinase activity in equine synovial fluid: influence of age, osteoarthritis, and osteochondrosis. Ann Rheum Dis 57 (1998) 697-699
69. Brama P.A.J., Van den Boom R., DeGroot J., et al. Collagenase-1 (MMP-1) activity in equine synovial fluid: influence of age, joint pathology, exercise and repeated arthrocentesis. Equine Vet J 36 (2004) 34-40
70. Jouglin M., Rober C., Valette J.P., et al. Metalloproteinase and tumor necrosis factor-alpha activities in synovial fluids of horses: correlation with cartilage alterations. Vet Res 31 (2000) 507-515
71. Brommer H., van Weeren P.R., and Brama P.A.J. New approach for quantitative assessment of articular cartilage degeneration in horses with osteoarthritis. Am J Vet Res 64 (2003) 83-87
72. Brama P.A.J., TeKoppele J.M., Beekman B., et al. Influence of development and joint pathology on stromelysin enzyme activity in equine synovial fluid. Ann Rheum Dis 59 (2000) 155-157
73. Maksymowych W.P., Ladewe R., Conner-Spady B., et al. Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum 56 (2007) 1846-1853
74. Blom A.B., van Lent P.L., Libregts S., et al. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3. Arthritis Rheum 56 (2007) 147-157
75. Brama PAJ, van den Boom R, van Weeren PR. Collagenase (MMP-1) activity in synovial fluid as a marker for joint pathology in the horse. In: Proceedings of the 41st Congress of the British Equine Veterinary Association. Harrogate (UK): British Equine Veterinary Association; 2002. p. 192.
76. Hurtig M., Green L., Dobson H., et al. Correlative study of defective cartilage and bone growth in foals fed a low copper diet. Equine Vet J Suppl 16 (1993) 66-73
77. Al-Hizab F., Clegg P.D., Thompson C.C., et al. Microscopic localisation of active gelatinases in equine osteochondritis dissecans (OCD) cartilage. Osteoarthritis Cartilage 10 (2002) 653-661
78. Dagleish M.P., Wakeman K.D., and McDiarmid A.M. A preliminary evaluation of the use of equine neutrophil elastase 2A concentration in synovial fluid as a marker for joint inflammation in horses. Equine Vet J 35 (2003) 623-626
79. Von Rechenberg B., McIlwraith C.W., Akens M.K., et al. Spontaneous production of nitric oxide (NO), prostaglandin (PGE2) and neutral metalloproteinases (NMPs) in media of explant cultures of equine synovial membrane and articular cartilage from normal and osteoarthritic joints. Equine Vet J 34 (2000) 140-150
80. Hinz B., and Brune K. Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol 16 (2004) 628-633
81. Laufer S. Role of eicosanoids in structural degradation in osteoarthritis. Curr Opin Rheumatol 15 (2003) 623-627
82. May S.A., Hooke R.E., Peremans K.Y., et al. Prostaglandin E2 in equine joint disease. Vlaamsch Diergeneeskundig Tijdschrift 63 (1994) 187-191
83. Trumble T.N., Billinghurst R.C., and McIlwraith C.W. Correlation of prostaglandin E2 concentrations in synovial fluid with ground reaction forces and clinical variables for pain or inflammation in dogs with osteoarthritis induced by transection of the cranial cruciate ligament. Am J Vet Res 65 (2004) 1269-1275
84. Bertone A.L., Palmer J.L., and Jones J. Synovial fluid inflammatory mediators as markers of equine synovitis. Vet Surg 22 (1993) 372-373
85. Bertone A.L., Palmer J.L., and Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Vet Surg 30 (2001) 528-538
86. Kageyama Y., Koide Y., Miyamoto S., et al. Leukotriene B4-induced interleukin-1 beta in synovial cells from patients with rheumatoid arthritis. Scand J Rheumatol 23 (1994) 148-150
87. Laufer S. Osteoarthritis therapy-are there still unmet needs?. Rheumatology (Oxford) 43 suppl 1 (2004) 9-15
88. Gibson K.T., Hodge H., and Whittem T. Inflammatory mediators in equine synovial fluid. Aust Vet J 73 (1996) 148-151
89. Owens J.G., Kamerling S.G., and Stanton S.R. Effects of pretreatment with ketoprofen and phenylbutazone on experimentally induced synovitis in horses. Am J Vet Res 57 (1996) 866-874
90. Lajeunesse D., and Reboul P. Subchondral bone in osteoarthritis: a biologic link with articular cartilage leading to abnormal remodelling. Curr Opin Rheumatol 15 (2003) 628-633
91. Martel-Pelletier J., Mineau F., Fahmi H., et al. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids. Arthritis Rheum 50 (2004) 3925-3933
92. Caron J.P. Neurogenic factors in joint pain and disease pathogenesis. In: McIlwraith C.W., and Trotter G.W. (Eds). Joint disease in the horse (1996), Saunders, Philadelphia 70-80
93. Levine J.D., Clark R., Devor M., et al. Intraneural substance P contributes to the severity of experimental arthritis. Science 226 (1984) 547-549
94. Appelgren A., Appelgren B., Kopp S., et al. Substance P-associated increase of intra-articular temperature and pain threshold in the arthritic TMJ. J Orofac Pain 12 (1998) 101-107
95. Fortier L.A., and Nixon A.J. Distributional changes in substance P nociceptive fiber patterns in naturally osteoarthritic articulations. J Rheumatol 24 (1997) 524-530
96. Bowker R.M., Abhold R.H., Caron P., et al. Neuropeptidergic innervation of equine synovial joints. Am J Vet Res 54 (1993) 1831-1839
97. Kirker-Head C.A., Chandna V.K., Agarwal R.K., et al. Concentrations of substance P and prostaglandin E2 in synovial fluid of normal and abnormal joints in horses. Am J Vet Res 61 (2000) 714-718
98. Pritchett J.W. Substance P level in synovial fluid may predict pain relief after knee replacement. J Bone Joint Surg Br 79 (1997) 114-116
99. Van den Boom R., Brama P.A.J., Kiers G.H., et al. The influence of repeated arthrocentesis and exercise on matrix metalloproteinase and tumour necrosis factor alpha activities in normal equine joints. Equine Vet J 36 (2004) 155-159
100. Cornelissen B.P.M., Rijkenhuizen A.B.M., and van den Hoogen B.M. Experimental model of synovitis/capsulitis in the equine metacarpophalangeal joint. Am J Vet Res 59 (1998) 978-985
101. Hawkins D.L., MacKay R.J., and Gum G.G. Effects of intra-articularly administered endotoxin on clinical signs of disease and synovial fluid tumor necrosis factor, interleukin 6, and prostaglandin E2 values in horses. Am J Vet Res 54 (1993) 379-386
102. Billinghurst R.C., Fretz P.B., and Gordon J.R. Induction of intra-articular tumour necrosis factor during acute inflammatory response in equine arthritis. Equine Vet J 27 (1995) 208-216
103. Fortier L.A., Kornatowski M.A., Mohammed H.O., et al. Age-related changes in serum insulin-like growth factor-I, insulin-like growth factor-I binding protein-3 and articular cartilage structure in Thoroughbred horses. Equine Vet J 37 (2005) 37-42
104. Goodrich L.R., Hidaka C., Robbins P.D., et al. Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. J Bone Joint Surg Br 89 (2007) 672-685
105. Tavera C., Abribat T., Reboul P., et al. IGF and IGF-binding protein system in the synovial fluid of osteoarthritic and rheumatoid arthritic patients. Osteoarthritis Cartilage 4 (1996) 263-274
106. Taylor D., and Lee T.C. Measuring the shape and size of microcracks in bone. J Biomech 31 (1998) 1177-1180
107. Riggs C.M., Whitehouse G.H., and Boyde A. Pathology of the distal condyles of the third metacarpal and third metatarsal bones of the horse. Equine Vet J 31 (1999) 140-148
108. Boyde A., and Firth E.C. Articular calcified cartilage canals in the third metacarpal bone of two year old Thoroughbreds. J Anat 205 (2004) 491-500
109. Firth E.C., and Hartman W. An in vitro study on joint fitting and cartilage thickness in the radiocarpal joint of foals. Res Vet Sci 34 (1983) 320-326
110. Brama P.A.J., Karssenberg D., Barneveld A., et al. Contact areas and pressure distribution on the proximal articular surface of the proximal phalanx under sagittal plane loading. Equine Vet J 33 (2001) 26-32
111. Firth E.C., Rogers C.W., Doube M., et al. Musculoskeletal responses of two year old thoroughbred horses to early training. 6. Bone parameters in third metacarpal and third metatarsal bones. N Z Vet J 53 (2005) 101-112
112. Grace N.D., Firth E.C., Shaw H.L., et al. Digestible energy intake, dry matter digestibility and effect of increased calcium intake on bone parameters of grazing New Zealand Thoroughbred weanlings. N Z Vet J 5 (2002) 165-173
113. Kawcak C.E., McIlwraith C.W., Norrdin R.W., et al. Clinical effects of exercise on subchondral bone of carpal and metacarpophalangeal joints in horses. Am J Vet Res 61 (2000) 1252-1258
114. Firth E.C., Rogers C.W., and Jopson N. Effects of race track exercise on third metacarpal and carpal bone of New Zealand thoroughbred horses. J Musculoskelet Neuronal Interact 1 (2000) 145-147
115. Firth E.C., Rogers C.W., van Weeren P.R., et al. Changes in diaphyseal and epiphyseal bone parameters in Thoroughbred horses after withdrawal from training. J Musculoskelet Neuronal Interact 6 (2007) 418-420
116. Markel M.D. Fracture healing and its non-invasive assessment. In: Nixon A. (Ed). Equine fracture repair (1996), WB Saunders, Philadelphia 19-29
117. Firth E.C. Problems in quantifying bone response to exercise in horses: a review. N Z Vet J 52 (2004) 216-229